文献速递冠心病

植入式心脏监测器实时报警减少急性冠脉综合征事件院前延迟

Implanted Monitor Alerting to Reduce Treatment Delay in Patients With Acute Coronary Syndrome Events.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

ALERTS关键研究纳入907例高复发ACS风险患者,随机分入报警开启或关闭组6个月,评估植入式心电监测器对ST段偏移的实时报警效果。结果显示报警开启组55%的ACS急诊就诊在2小时内,而报警关闭组仅10%,心肌梗死院前延迟中位数从12.7小时降至1.6小时。

要点

  • 植入式监测器实时报警使ACS事件2小时内就诊比例从10%提升至55%
  • 心肌梗死院前延迟中位数从12.7小时降至1.6小时
  • 无症状心梗报警至就诊中位延迟为1.4小时

核心结论

  • 植入式心脏监测器实时报警可显著减少ACS事件中超过2小时的院前延迟,包括无症状心梗。

研究设计与样本

  • ALERTS关键研究为随机对照试验,纳入907例高复发ACS风险受试者,随机分为报警关闭组和报警开启组6个月。

主要发现

  • 报警开启组55%(95%CI 46%–63%)的ACS急诊就诊在2小时内,报警关闭组为10%(95%CI 2%–27%),P<0.0001。
  • 心肌梗死院前延迟中位数报警关闭组为12.7小时,报警开启组为1.6小时,P<0.0089。
  • 无症状心梗报警至就诊中位延迟为1.4小时。
  • 报警开启组中仅症状触发(无报警)的心梗症状至就诊中位延迟为4.3小时。

关键数值与推荐

  • 报警开启组ACS事件2小时内就诊比例为55%,报警关闭组为10%。

临床怎么用

  • 对于高复发ACS风险患者,植入式心脏监测器实时报警可能有助于缩短院前延迟。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increased pre-hospital delay during acute coronary syndrome (ACS) events contributes to worse outcome. OBJECTIVES: The purpose of this study was to assess the effectiveness of an implanted cardiac monitor with real-time alarms for abnormal ST-segment shifts to reduce pre-hospital delay during ACS events. METHODS: In the ALERTS (AngeLmed Early Recognition and Treatment of STEMI) pivotal study, subjects at high risk for recurrent ACS events (n = 907) were randomized to control (Alarms OFF) or treatment groups for 6 months, after which alarms were activated in all subjects (Alarms ON). Emergency department (ED) visits with standard-of-care cardiac test results were independently adjudicated as true- or false-positive ACS events. Alarm-to-door (A2D) and symptom-to-door (S2D) times were calculated for true-positive ACS ED visits triggered by 3 possible prompts: alarm only, alarms + symptoms, or symptoms only. RESULTS: The Alarms ON group showed reduced delays, with 55% (95% confidence interval [CI]: 46% to 63%) of ED visits for ACS events <2 h compared with 10% (95% CI: 2% to 27%) in the Alarms OFF group (p < 0.0001). Results were similar when restricted to myocardial infarction (MI) events. Median pre-hospital delay for MI was 12.7 h for Alarms OFF and 1.6 h in Alarms ON subjects (p < 0.0089). Median A2D delay was 1.4 h for asymptomatic MI. Median S2D delay for symptoms-only MI (no alarm) in Alarms ON was 4.3 h. CONCLUSIONS: Intracardiac monitoring with real-time alarms for ST-segment shift that exceeds a subject's self-normative ischemia threshold level significantly reduced the proportion of pre-hospital delays >2 h for ACS events, including asymptomatic MI, compared with symptoms-only ED visits in Alarms OFF. (AngeLmed for Early Recognition and Treatment of STEMI [ALERTS]; NCT00781118).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Holmes DR, Krucoff MW, Mullin C, et al. Implanted Monitor Alerting to Reduce Treatment Delay in Patients With Acute Coronary Syndrome Events. J Am Coll Cardiol. 2019. PMID: 31623762. doi:10.1016/j.jacc.2019.07.084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。